Discontinuation and remission rates and social functioning in patients with schizophrenia receiving second-generation antipsychotics: 52-week evaluation of JUMPs, a randomized, open-label study.
Ishigooka J, Nakagome K, Ohmori T, Iwata N, Inada K, Iga JI, Kishi T, Fujita K, Kikuchi Y, Shichijo T, Tabuse H, Koretsune S, Terada H, Terada H, Kishimoto T, Tsutsumi Y, Kanda Y, Ohi K, Sekiyama K.
Ishigooka J, et al. Among authors: terada h.
Psychiatry Clin Neurosci. 2022 Jan;76(1):22-31. doi: 10.1111/pcn.13304. Epub 2021 Nov 17.
Psychiatry Clin Neurosci. 2022.
PMID: 34626144
Free PMC article.
Clinical Trial.